He Fuxian – Trademark Portfolio

Entity Type: 01

He Fuxian owns a portfolio of 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as LETVI, PLAMAZ, and PLOMAS. Of these, 3 are registered. The portfolio spans 3 Nice Classification classes, led by Class 18 (Leather Goods) and Class 10 (Medical Apparatus). Headquartered in Guangdong Province.

Room 101,No.43,Luzhou Village,Shijiao

Guangdong Province 524462 , CN

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

PLAMAZ
PLAMAZ
Registered 2022
PLOMAS
PLOMAS
Registered 2022
LETVI
LETVI
Registered 2022

Trademark Classifications

He Fuxian's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

18
Leather Goods (1 filing)

Leather and imitations of leather; animal skins, hides; trunks and travelling bags

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

16
Paper Goods (1 filing)

Paper and cardboard; printed matter; bookbinding material; photographs; stationery

Frequently Asked Questions

How many trademarks does He Fuxian have?

He Fuxian has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does He Fuxian file in?

He Fuxian files trademarks across 3 Nice Classification classes. The most active classes are Class 18 (Leather Goods), Class 10 (Medical Apparatus), Class 16 (Paper Goods). Class 18 covers leather and imitations of leather; animal skins, hides; trunks and travelling bags.

What are He Fuxian's most well-known trademarks?

He Fuxian's registered trademark portfolio includes well-known marks such as LETVI, PLAMAZ, and PLOMAS. These are among 3 currently registered trademarks in the portfolio.

What is He Fuxian's trademark registration success rate?

He Fuxian has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.